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“Black” pigment gallstones form in sterile gallbladder bile in the presence of excess 39 
bilirubin conjugates (“hyperbilirubinbilia”) from ineffective erythropoiesis, hemolysis or 40 
induced enterohepatic cycling (EHC) of unconjugated bilirubin.  Impaired gallbladder 41 
motility is a less well-studied risk factor.  We evaluated the spontaneous occurrence of 42 
gallstones in adult germfree (GF) and conventionally housed specific pathogen-free 43 
(SPF) Swiss Webster (SW) mice.  GF SW mice were more likely to have gallstones than 44 
SPF SW mice, with 75% and 23% prevalence, respectively.  In GF SW mice, gallstones 45 
were observed predominately in heavier, older females.  Gallbladders of GF SW mice 46 
were markedly enlarged, contained sterile “black” gallstones comprised of calcium 47 
bilirubinate and <1% cholesterol, and had low-grade inflammation, edema and epithelial 48 
hyperplasia.  Hemograms were normal, but serum cholesterol was elevated in GF 49 
compared to SPF SW mice, and serum glucose levels were positively related to 50 
increasing age.  Aged GF and SPF SW mice had deficits in gallbladder smooth muscle 51 
activity.  In response to cholecystokinin (CCK), gallbladders of fasted GF SW mice 52 
showed impaired emptying (females: 29%; males: 1% emptying), whereas SPF SW 53 
females and males emptied 89% and 53% of volume, respectively.  Bilirubin secretion 54 
rates of GF SW mice were not greater than SPF SW mice, repudiating an induced EHC.  55 
Gallstones likely developed in GF SW mice due to gallbladder hypomotility, enabled by 56 
features of GF physiology, including decreased intestinal CCK concentration and delayed 57 
intestinal transit, as well as an apparent genetic predisposition of the SW stock.  GF SW 58 
mice may provide a valuable model to study gallbladder stasis as a cause of “black” 59 
pigment gallstones. 60 
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Gallstone disease affects more than 20 million people in the United States and results in 66 
more than 700,000 cholecystectomies annually (32, 45, 46).  Although not widely 67 
studied, pigment gallstones are observed in a variety of clinical conditions, and may 68 
account for up to 20-25% of gallstones among patients that undergo cholecystectomy in 69 
the Western world (19, 37, 55).  While “brown” pigment gallstones form in septic bile, 70 
“black” pigment gallstones develop classically in sterile bile with the critical risk factor 71 
of hyperbilirubinbilia, defined as biliary hypersecretion of bilirubin conjugates, due 72 
principally to chronic hemolysis secondary to multiple syndromes, or ineffective 73 
erythropoiesis as seen with vitamin B12 and folate deficiencies (38, 48, 54, 55).  74 
Hyperbilirubinemia may also occur with prolonged intestinal transit, antibiotic therapy 75 
and ileal dysfunction from induced enterohepatic cycling (EHC) of unconjugated 76 
bilirubin (UCB), wherein UCB enters the enterohepatic circulation to be reconjugated, 77 
and resecreted into bile (18, 53-56).  78 
A pathophysiological role for intestinal bacteria, or the lack thereof, in “black” 79 
pigment gallstone formation has not been well-documented, but may involve altered 80 
intestinal mucosal barrier function, and changes in intestinal bilirubin deconjugation and 81 
formation of urobilinoids, facilitating EHC of UCB (9, 47, 54, 55, 59).  The Division of 82 
Comparative Medicine at M.I.T. maintains a germfree (GF) Swiss Webster (SW) 83 
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breeding colony to facilitate embryo transfer rederivation of other lines of mice into a GF 84 
status, and periodically purchases conventionally housed specific pathogen-free (SPF) 85 
SW mice for controls in various research studies.  SW mice are customarily used as an 86 
inexpensive outbred stock for biomedical research, transgenic technology, and as sentinel 87 
mice for monitoring infectious diseases in research colonies.  Interestingly, necropsies of 88 
adult female and male GF SW mice from our colony revealed 100% prevalence of 89 
markedly enlarged gallbladders, with 75% containing gallstones morphologically 90 
consistent with “black” pigment gallstones of humans, whereas SPF SW mice 91 
demonstrated 23% gallstone prevalence and normal sized gallbladders.  92 
It is known that GF mice have delayed intestinal transit, with documented two 93 
times less cholecystokinin (CCK)-like immunoreactivity in the small intestine from rapid 94 
degradation of CCK, compared to normally colonized mice, and that CCK acts to 95 
promote propulsive activity of the intestine (30, 34, 35, 50, 57, 61).  The slower intestinal 96 
transit observed in GF mice is reminiscent of the altered peristaltic function in humans 97 
and experimental animals with cholesterol gallstone disease (36, 37, 58, 61).  Although 98 
dysfunction in gallbladder and small intestinal motility has been linked to cholesterol 99 
gallstone disease, little is known about how hypomotility of the gallbladder influences 100 
“black” pigment gallstone formation (36, 37, 58).  Gallbladder dysfunction has been 101 
reported in conditions associated with the formation of “black” pigment gallstones, 102 
including liver cirrhosis, truncal vagotomy and administration of total parenteral 103 
nutrition, and in conditions more often associated with cholesterol gallstones such as 104 
obesity and/or type II diabetes (4, 36, 37, 49, 54, 58).  With recognized delayed intestinal 105 
transit in GF mice and the indefinite association of “black” pigment gallstones with 106 
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gallbladder dysfunction in humans, we postulated that GF SW mice may provide a 107 
unique, spontaneous animal model to investigate the role of the gut microbiota and 108 
impaired gallbladder motility in “black” pigment gallstone formation in humans. 109 
In turn, we characterized gallstone disease in GF and SPF SW mice by 110 
demographic profiling, logistic regression analysis, various gallbladder bile and gallstone 111 
analyses, and gallbladder and liver histology.  Mice were screened for hematopoietic 112 
abnormalities, and conjugated and unconjugated bilirubin levels in hepatic bile 113 
determined to rule out ineffective erythropoiesis or hemolysis, and induced EHC of UCB, 114 
respectively.  The proposed mechanism of impaired gallbladder motility was probed by 115 
determination of fasting gallbladder volumes and bile pH, screening for metabolic 116 
abnormalities such as diabetes, and evaluation of calcium ion (Ca2+) activity of 117 




GF outbred Tac:SW mice were obtained from Taconic Farms (Germantown, NY) and 122 
maintained as a breeding colony in a facility accredited by the Association for the 123 
Assessment and Accreditation of Laboratory Animal Care, International.  One hundred 124 
and twenty-five female and 99 male GF SW mice were bred periodically and aged further 125 
for purposes of this study (age range: 5 - 22 months; 10.7 ± 0.2 months old) (Table 1).  126 
For comparison to GF SW mice, SPF mice representing the same outbred genetic stock 127 
but colonized with intestinal microbiota were evaluated.  Seventy-five female and 53 128 
male SPF SW mice were purchased from Taconic as retired breeders (age range: 8 - 15 129 
6 
months; 10.1 ± 0.2 months old) (Table 1).  SPF SW mice were free of exogenous murine 130 
viruses, bacterial pathogens and parasites, and animal use was approved by the 131 
Institutional Animal Care and Use Committees of the collaborating institutions. 132 
Husbandry 133 
GF SW mice were housed in sterile isolators in open-top polycarbonate cages on 134 
autoclaved hardwood bedding and fed autoclaved water and diet (Purina 5021, Purina 135 
Mills, St. Louis, MO) ad libitum.  The diet had a guaranteed analysis of not less than 20% 136 
crude protein and 9% crude fat, and not more than 5% crude fiber and 6.5% ash.  137 
Macroenvironmental conditions included a 14:10 light / dark cycle and temperature 138 
maintenance at 68 ± 2ºF.  Weekly microbiologic monitoring of interior isolator surfaces, 139 
feed, water, and feces confirmed absence of all aerobic and anaerobic bacteria and fungi.  140 
SPF SW mice were housed in a barrier facility in standard, non-autoclaved microisolator 141 
cages under similar environmental conditions.  To standardize nutrition, these mice were 142 
fed the same autoclaved diet for the duration of their lives.  SPF status was monitored by 143 
a sentinel program. 144 
Determination of Gallbladder Volume and Bile pH 145 
Mice were euthanized using carbon dioxide and at necropsy, relative gallbladder size and 146 
gross evidence of gallstones (relative size, approximate amount and color) were recorded. 147 
Gallbladder volume (µL) and pH of gallbladder bile were determined for fasted 148 
GF (n = 6 females, 6 males; 12.0 ± 0.9 months old) and SPF (n = 14 females, 15 males; 149 
11.2 ± 0.6 months old) SW mice.  Mice were anesthetized by intraperitoneal injection of 150 
a cocktail of anesthetics in 9% NaCl, containing ketamine (80 mg/kg), xylazine (8 151 
mg/kg), acepromazine (2 mg/kg) and atropine (0.012 mg/kg), and terminal 152 
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cholecystectomies were performed as previously described (18).  Following gallbladder 153 
removal, mice were euthanized by anesthetic overdose, followed by bilateral 154 
thoracotomy.  Gallbladder bile was drained into tared 200 µL microcentrifuge tubes, and 155 
gallbladder volumes were quantified gravimetrically by equating weight and volume (i.e., 156 
1 mg = 1 µL).  Immediately afterwards, gallbladder bile pH was measured by a micro pH 157 
electrode (Microelectrodes Inc., Bedford, NH).  158 
Gallbladder Bile and Gallstone Analyses 159 
To characterize gallbladder bile sediment and gallstone morphology, fresh and previously 160 
frozen (-70°C) gallbladder bile samples from GF SW mice with (n = 5 females, 2 males; 161 
16.9 ± 2.0 months old) or without (n = 3 males; 10.3 ± 2.3 months old) gross evidence of 162 
gallstones were evaluated microscopically under direct light.  These samples from GF 163 
SW mice were compared to bile of 7 SPF SW mice (n = 3 females, 4 males; 10 months 164 
old) lacking gross evidence of gallstones and one 15-month-old SPF SW female mouse 165 
with gallstones, though the latter sample was kept at room temperature for an extended 166 
period of time prior to analysis.  Additionally, fresh gallbladder tissue, bile and gallstones 167 
from seven 11-month-old GF SW female mice (n = 5 with gallstones) were examined by 168 
direct light and polarized light microscopy. 169 
Gallstones from two 15-month-old and two 22-month-old GF SW females and 170 
one 15-month-old GF SW male were sent to the Laboratory for Stone Research (Newton, 171 
MA) for compositional analysis by polarized light microscopy and infrared spectroscopy.  172 
To determine cholesterol content of gallstones, microcentrifuge tubes containing 173 
gallstones in bile from 9-month-old GF (n = 5 females, 4 males) and SPF (n = 3 females) 174 
SW mice were centrifuged for 15 min in a tabletop microcentrifuge (ISC BioExpress, 175 
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Kaysville, UT).  After bile supernatant was removed, gallstones were washed by 176 
vortexing thoroughly with 200 µL of 1% (w/v) Na tauroursodeoxycholate (NaTUDC).  177 
Then, samples from GF SW males and from SPF SW females were pooled into 1 sample 178 
per group, whereas gallstones from female GF SW mice were combined into 2 samples.  179 
Samples were washed 3 more times with 200 µL NaTUDC and then layered carefully 180 
onto a Nuclepore polycarbonate membrane filter (47 mm, 0.2 µm), washed with 5 mL 181 
double distilled water, and filter dried under house vacuum.  Filter residue was carefully 182 
scraped with the flat edge of a metal spatula and transferred to a tared aluminum 183 
weighing dish that had been dried under house vacuum at 60˚C for 24 hours (hr).  Dried 184 
gallstone samples were then resuspended in 150 µL isopropanol.  Clumps were broken 185 
gently with a glass stirring rod, samples vortexed for 4 min and incubated at 37˚C for 2 hr 186 
in a shaking water bath.  Immediately prior to analysis, 450 µL acetonitrile was added to 187 
each sample.  Gallstones were analyzed for cholesterol content by a modified HPLC 188 
method using a Kinetex C18 column (2.6 µm particle size; Phenomenex, Torrance, CA) 189 
and eluting with acetonitrile:isopropanol (3:1, v/v)  (52).  190 
Gallstones from 12-month-old GF (n = 3 females, 3 males; pooled into 1 sample) 191 
and SPF (n = 1 female) SW mice were also analyzed by electron paramagnetic resonance 192 
(EPR) spectroscopy.  Gallbladder bile supernatant was removed and gallstones were 193 
washed five times with Chelex-treated water.  The water was obtained from a Milli-Q 194 
purification system (18.2 mΩcm-1) and treated with Chelex resin (Biorad, 10 g/L, stirred 195 
for >1 hr and filtered) to remove contaminating metal ions prior to use.  For washing, the 196 
gallstones were suspended in 180 µL of Milli-Q water in the sample reservoir of a 197 
centrifugal filter device, gently vortexed, and centrifuged [10,000 rpm x 5 minutes (min), 198 
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20oC].  The washed gallstones remaining in the reservoir were re-suspended in the 199 
Chelex-treated water (180 µL), transferred to acid-washed (2 M HCl) quartz EPR tubes 200 
and frozen in liquid nitrogen prior to analysis and stored at -80oC.  A sample of 201 
commercial bilirubin [98% (EmM/453 = 60); Sigma-Aldrich] was prepared in Chelex-202 
treated Milli-Q water and frozen in liquid nitrogen prior to analysis.  EPR spectra (X-203 
band, 9 GHz) were recorded on a Bruker EMX spectrometer with an ER 4199HS cavity.  204 
An ESR900 cryostat outfitted with a Cernox sensor was employed for all measurements.  205 
Unless noted otherwise, the modulation amplitude and frequency was 1 mT at 100 kHz. 206 
Samples of twice washed gallstones (4 samples pooled into 1 sample) and undiluted 207 
gallbladder bile (1 individual sample) from 14-month-old female GF SW mice, as well as 208 
gallstones washed five times (4 samples pooled into 1 sample) from 15-month-old GF 209 
SW mice were also analyzed.  210 
Additional gallstones and gallbladder bile from GF (n = 2 females, 4 males; 12 211 
months old) and SPF (n = 3 females; 11 months old) SW mice were aseptically collected 212 
for culture under aerobic and anaerobic (gas mix) conditions to confirm absence of 213 
gallbladder infection. 214 
Screening for Hematopoietic or Metabolic Abnormalities 215 
Following an overnight fast and carbon dioxide euthanasia, post-mortem cardiac blood 216 
was collected for complete blood count (CBC) from 11 female and 12 male GF SW mice 217 
(10.8 ± 0.6 months old), and 3 female and 3 male SPF SW mice (12 months old), and for 218 
serum chemistry analysis from 11 female and 15 male GF SW mice (12.7 ± 1.1 months 219 
old), and 4 female and 5 male SPF SW mice (10 months old).  CBCs were measured 220 
using a Hemavet 950FS analyzer (Drew Scientific, Waterbury, CT) and serum was sent 221 
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to IDEXX Laboratories (Memphis, TN) for a chemistry panel of 21 analytes [Table 5; 3 222 
analytes (bicarbonate, creatine kinase, gamma-glutamyl transferase) excluded due to 223 
insufficient quantity for comparison]. 224 
Because a predisposition to diabetes mellitus was previously reported for Tac:SW 225 
mice, GF and SPF SW mice were screened for glucosuria, fasting hyperglycemia (>300 226 
mg/dL) and glucose intolerance (29, 39, 40), and pancreata were examined histologically.  227 
Naturally voided urine was collected in sterile polycarbonate caging, or via post-mortem 228 
cystocentesis from 11 female and 3 male GF SW mice (11.0 ± 0.7 months old), and 5 229 
female SPF SW mice (12 months old).  Clinical urinalysis dipsticks (Multistix 10 SG, 230 
Siemens Healthcare Diagnostics, Tarrytown, NY) were used to measure protein, glucose, 231 
leukocytes, nitrites, ketones, bilirubin, blood and urobilinogen.  Specific gravity was 232 
measured when a sufficient urine volume was collected.   233 
Glucose tolerance testing (GTT) was performed on 9-month-old GF (n = 6 234 
females, 5 males) and SPF (n = 6 females, 6 males) SW mice.  Mice were fasted 235 
overnight, weighed, and baseline glucose was measured in blood obtained by tail nick, 236 
followed by intraperitoneal injection of 1 gram of 10% dextrose per kg body weight.  237 
Blood glucose levels were measured using a glucometer (AlphaTRAK, Abbott 238 
Laboratories, Abbott Park, IL) at time 0, 15, 30, 60, 90, and 120 min post glucose dosing.   239 
Additional serum samples were collected 2 days later from these same mice after 240 
an 8 hr fast for measurement of serum glucose and insulin levels by the Mouse 241 
Metabolism Core (MMC; Baylor College of Medicine, Diabetes and Endocrinology 242 
Research Center, Houston, TX).  Cardiac blood was collected following carbon dioxide 243 
euthanasia.  Sera from 12-month-old GF (n = 4 females, 4 males) and SPF (n = 3 244 
11 
females, 3 males) SW mice were collected for glucose and glycated hemoglobin (HbA1c) 245 
levels performed by the Comparative Pathology Laboratory (CPL; University of 246 
California, School of Veterinary Medicine, Davis, CA). 247 
Histology 248 
Abdominal organs were evaluated grossly at necropsy and gallbladder, liver, pancreas 249 
and kidneys were fixed in buffered 10% formalin and processed for histology.  Formalin-250 
fixed tissues were evaluated from GF SW mice with gallstones (n = 11 females, 7 males; 251 
14.1 ± 1.3 months old), without gallstones (n = 1 female, 7 males; 10.5 ± 1.2 months old), 252 
and from SPF SW mice without gallstones (n = 6 females, 6 males; 9.5 ± 0.3 months 253 
old).  Tissues were embedded in paraffin, sectioned at 4 µm, stained with hematoxylin 254 
and eosin (H&E), and evaluated by a board-certified veterinary pathologist blinded as to 255 
sample identity.  Gallbladders were graded semi-quantitatively on a scale of 0 (normal) to 256 
3 (severe) for histomorphological changes, including inflammation, edema, hyalinosis, 257 
metaplasia, hyperplasia and dysplasia.  The liver, pancreas and kidneys were qualitatively 258 
assessed for any relevant pathology.  Because mild liver lesions were observed in some 259 
mice, liver sections were further assessed on a scale of 0 to 4 for lobular and portal 260 
inflammation, and dysplasia/neoplasia.  The number of lobes with >5 inflammatory foci 261 
was used to calculate a cumulative hepatitis index score, as previously described (41).  262 
Gallbladder Muscle Activity 263 
Calcium imaging studies were performed as previously described in greater detail (25).  264 
Age-matched GF and SPF SW female mice (10 months old; n = 4 per group) were 265 
anesthetized with isoflurane, exsanguinated and underwent cholecystectomy.  266 
Gallbladders were opened and mounted serosa side up between two pieces of Sylgard 267 
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(Dow Corning, Midland, MI) connected by metal pins.  Mounted tissues were incubated 268 
in HEPES buffer containing 10 µM fluo-4 AM and 2.5 µg/ml pluronic acid for 45 min at 269 
room temperature, and then rinsed in HEPES buffer for at least 30 min to allow de-270 
esterification.  The fluo-4- loaded gallbladders were placed in an imaging chamber and 271 
superperfused with aerated physiological saline solution (PSS). Ca2+ transients were 272 
visualized using a Nikon TMD inverted microscope with a 60x water immersion lens 273 
attached to a Noran Oz laser confocal system.  After a 20 min equilibration period, basal 274 
Ca2+ activity was recorded over periods of 30 to 60 seconds (15-30 frames per second), 275 
from three to seven fields per gallbladder.  To measure agonist-induced Ca2+ activity, 276 
carbachol (3 µM in PSS) was superfused over the tissue and Ca2+ transients were 277 
recorded every few minutes over a 20 min period.  Data were analyzed using SparkAN, a 278 
custom software program written at the University of Vermont, and also compared to 279 
baseline data obtained from 7-10-week-old SPF SW males. 280 
Responsiveness to Exogenous Cholecystokinin 281 
Fasted GF (n = 9 females, 10 males; 8 months old) and SPF (n = 8 females, 7 males; 8 282 
months old) SW mice were administered cholecystokinin octapeptide (CCK) to evaluate 283 
gallbladder emptying.  Under injectable anesthesia described above, mice were injected 284 
intravenously with 2 µL/g of CCK solution (10-5 mg/mL sulfated CCK; Tocris 285 
Bioscience, Bristol, UK) in sterile PBS, pH 7.4.  After 20 min, cholecystectomies were 286 
performed and gallbladder volumes (µL) were determined as described above.  Age-287 
matched fasted controls (GF SW mice: n = 9 females, 9 males; SPF SW mice: n = 7 288 
females, 9 males) received an injection of sterile PBS or no injection.  289 
Analysis of Conjugated and Unconjugated Bilirubin in Hepatic Bile 290 
13 
Conjugated and unconjugated bilirubin concentrations (µM) and secretion rates (nmol/hr) 291 
in hepatic bile were determined for unfasted GF (n = 19 females, 8 males; 11.1 ± 0.1 292 
months old) and SPF (n = 15 females, 7 males; 11.3 ± 0.5 months old) SW mice.  Mice 293 
were induced with an anesthetic cocktail administered intraperitoneally as described 294 
above.  Following cannulation of the hepatic bile duct, hepatic biliary outputs and 295 
secretion rates were assessed as previously described (17).  To prevent actinic and 296 
oxidative degradation of bilirubin, hepatic bile was kept in the dark and/or under red 297 
lights.  Hepatic biliary species were determined and quantified by HPLC using the 298 
method of Spivak and Yuey (44).  Percent UCB (%) was calculated by dividing the 299 
concentration of UCB by the sum of the concentrations of all individual bilirubin species 300 
(i.e., all mono- and di-conjugates, plus UCB).  Secretion rates were normalized to 1 hr of 301 
hepatic bile flow. 302 
Statistics  303 
Table 1 provides demographic data on SW mice with and without gallstones.  Logistic 304 
regression was performed to determine the likelihood of SW mice having gallstones 305 
(binary variable), controlling for microbial status (GF or SPF; binary variable), age 306 
(continuous variable), sex (binary variable) and body weight (continuous variable), and 307 
was reported through adjusted (crude) odds ratios (OR), 95% confidence intervals (95% 308 
CI), and p-values of the overall test of the model and each parameter estimate.  For each 309 
covariate, the likelihood-ratio chi-squared test for parameter estimates was used to 310 
compare the full logistic model to a model excluding the covariate of interest.  The 311 
favored model included only covariates found to contribute to the predictability of the 312 
model.  All possible interactions in the favored model were evaluated as a set to 313 
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determine significance using a chi-squared test to compare the favored logistic models, 314 
with or without the set of interaction variables.  Confounders were defined as covariates 315 
that, when added to the favored model, resulted in ≥10% change in the slope of the major 316 
exposure, microbial status.  Further, a stratified logistic regression analysis was 317 
performed as described above and was segregated by microbial status, with age as the 318 
major exposure and sex and body weight as covariates.     319 
Presence of gallstones, microbial status, age, sex and body weight were tested 320 
against individual quantitative analytes to determine significant effect(s) by analysis of 321 
covariance (ANCOVA), also with separate ANCOVAs performed for both microbial 322 
statuses.  Adjusted means were calculated for both microbial statuses, with the 323 
continuous variables (age, body weight) fixed at their means; data was reported as 324 
adjusted mean ± standard error.  Percentage data (hematocrit, HbA1c, unconjugated 325 
bilirubin) were arcsin transformed prior to analysis; reported adjusted mean ± standard 326 
error reflects untransformed data.  327 
Where ANCOVAs were not performed, GF and SPF SW mice were compared 328 
and further analyzed within both microbial statuses by presence of gallstones and sex.  329 
Age and body weight values were also compared between GF and SPF SW mice 330 
analyzed using a two-sample test of group means assuming equal variance (two-tailed), 331 
and reported as mean ± standard error.  Glucose tolerance testing data was analyzed using 332 
a two-sample test of group means (two-tailed), for comparison between groups at 333 
baseline and to determine the level of statistical significance when the difference between 334 
the mean area under the curves (AUC), determined by the trapezoidal rule with baselines 335 
set at zero, of two groups was considered.  Median pathology scores were compared 336 
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between groups using a Mann-Whitney two-sample rank-sum test.  To analyze 337 
gallbladder muscle activity, a one-way analysis of variance (ANOVA) with Bonferroni 338 
adjustment for multiple comparisons between groups was used.   339 
Statistical analysis was performed using STATA/IC 13.0 for Mac (StataCorp; 340 
College Station, TX) and Prism Version 5.0 (GraphPad Software; La Jolla, CA), with 341 
p<0.05 considered statistically significant.   342 
 343 
RESULTS 344 
GF SW mice had markedly enlarged gallbladders, irrespective of gallstones 345 
Necropsy of GF SW mice revealed that 169 of 224 mice (75%) showed gallbladders 346 
containing grossly visible, variably sized gallstones numbering from few to numerous 347 
(Table 1; Figure 1A-C).  Fasted and non-fasted GF SW mice had markedly enlarged 348 
gallbladders that commonly measured 1.0 cm long by 0.5 cm wide (Figure 1A-B).  Most 349 
SPF SW mice (77%; 98/128) displayed normal appearing gallbladders with no gross 350 
evidence of gallstones (Table 1).  However, 15 female and 15 male (23%) gallbladders 351 
contained gallstones (Table 1).   352 
GF SW mice (n = 12; 5 females, 4 males with gallstones) exhibited greater 353 
gallbladder volumes (179.0 ± 18.8 µL; SPF SW mice: 73.6 ± 11.3 µL) and lower pH of 354 
gallbladder bile (6.8 ± 0.1; SPF SW mice: 7.4 ± 0.1) compared to SPF SW mice (n = 29; 355 
1 female, 5 males with gallstones).  Statistically significant differences were unrelated to 356 
presence of gallstones, age or body weight, but related to microbial status [gallbladder 357 
volume: F(1, 35) = 20.37, p<0.001; gallbladder bile pH: F(1, 35) = 11.56, p<0.01] and 358 
sex [gallbladder volume: F(1, 35) = 28.51, p<0.0001; gallbladder bile pH: F(1, 35) = 359 
16 
10.31, p<0.01] (Figure 1D-E).  When analysis was stratified by microbial status, 360 
differences in bile pH according to sex were found to be non-significant, whereas 361 
significant effects were maintained on gallbladder volume in both GF (p<0.01) and SPF 362 
(p<0.001) SW mice, with females (GF SW mice: 229.4 ± 20.2 µL; SPF SW mice: 124.0 363 
± 15.2 µL) containing greater gallbladder volumes than males (GF SW mice: 130.9 ± 364 
21.6 µL; SPF SW mice: 25.6 ± 14.0 µL) (Figure 1D-E). 365 
Gallstones developed predominantly in obese, older female GF SW mice 366 
Using logistic regression, the odds of developing gallstones for GF SW mice was 11 367 
times those of SPF SW mice, controlled for age and body weight (p<0.001) (Table 2).  368 
Additionally, a one month increase in age and a one gram increase in body weight of SW 369 
mice increased the odds of developing gallstones by 15% (p<0.01) and 5% (p<0.01), 370 
respectively (Table 2).  Sex was found non-predictive in the full model, and no 371 
interaction or confounding was demonstrated. 372 
Stratified logistic regression revealed the odds of developing gallstones for female 373 
GF SW mice was 3 times those of males, controlled for age and body weight (p<0.01) 374 
(Table 3).  Further, a one month increase in age and a one gram increase in body weight 375 
of GF SW mice increased the odds of developing gallstones by 23% (p<0.01) and 8% 376 
(p<0.01), respectively (Table 3).  Of the 169 GF SW mice with gallstones, 105 (62%) 377 
were females and 64 (38%) were males of similar age.  Of the 55 mice without 378 
gallstones, 20 (36%) were females, and 35 (64%) were males.  Stratified logistic 379 
regression analysis found no significant predictability for presence of gallstones in SPF 380 
SW mice, controlling for age, sex and body weight.   381 
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Gallstone morphologic features and composition were consistent with “black” 382 
pigment gallstones 383 
Gallstones were variable in size (all less than 1 mm), and their color ranged from yellow 384 
to dark brown to black.  On average, gallstones from GF SW mice were grossly dark in 385 
color and durable (Figure 1A-C), whereas SPF SW gallstones were pale and friable.   386 
Gallstones from GF SW mice viewed under direct light microscopy had well 387 
defined smooth edges and were yellow to light brown on the outside, with a more 388 
pigmented, darker brown core (Figure 1F).  Using polarized light microscopy, the 389 
outermost aspect of the gallstones was almost translucent and revealed speckles of 390 
birefringent material, but not distinct crystals (Figure 1H-I).  Direct light microscopy of 1 391 
gallstone sample from an SPF SW mouse showed a few gallstones that were much lighter 392 
in color and lacked a dark core (Figure 1G).  Direct light microscopy of gallbladder bile 393 
from GF and SPF SW mice lacking visible gallstones revealed pale to light brown, 394 
amorphous sediment, which was also present in the bile from GF SW mice with 395 
gallstones (Figure 1F). 396 
 Gallstones from a 15-month-old female GF SW mouse analyzed by the 397 
Laboratory for Stone Research by polarized light microscopy and infrared spectroscopy 398 
were composed of “100%” calcium bilirubinate; note that no crystalline substances were 399 
observed, and acid or neutral salts were not defined, but was likely Ca(HUCB)2 based on 400 
gallbladder bile pH.  The remainder of gallstones submitted for analysis contained non-401 
crystalline, undefined proteinaceous material.   402 
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Cholesterol content was <1% cholesterol content in all gallstone samples analyzed 403 
(GF SW females: 0.7%; GF SW males: 0.6%; SPF SW females: 0.1%).  Aerobic and 404 
anaerobic cultures of GF and SPF SW gallstones and gallbladder bile were negative.   405 
EPR spectroscopic analysis supported the presence of bilirubin radicals in SW 406 
gallstones 407 
Previous reports have indicated the presence of EPR-detectable transition metals ions, 408 
specifically Mn2+, Cu2+ and Fe3+, as well as bilirubin radicals in “black” pigment 409 
gallstones (7, 13).  In our study, EPR-detectable species were identified in samples of 410 
gallstones that were washed two (GF SW) and five (GF and SPF SW) times, and in 411 
gallbladder bile (GF SW).  EPR spectroscopic analysis of the gallstones washed five 412 
times from GF and SPF SW mice revealed features consistent with those observed for 413 
commercial bilirubin: the signal centered at g = 2.00 indicates a radical species and is 414 
attributed to the presence of bilirubin radicals (Figure 2, Top Panel).   415 
 Signals from EPR-detectable transition metal ions attributed to Mn2+ (g = 2.01, a 416 
= 8.9 mT), Cu2+ (g = 2.27, a = 16 mT), and Fe3+ (g = 4.31) were observed in twice 417 
washed gallstones and gallbladder bile obtained from GF SW mice (Figure 2, Middle 418 
Panel).  Signals from Mn2+ and Cu2+ are visible in the g = 2 region of the spectra, and the 419 
expected hyperfine patterns (4-line, a = 16 mT from the I = 3/2 Cu nucleus; 6-line, a = 420 
8.9 mT from the I = 5/2 55Mn nucleus) from these individual species overlap 421 
considerably.  The observed pattern of lines around g = 2.01 for a gallbladder bile sample 422 
(vide infra) could be accurately reproduced by the summation of spectra obtained for 423 
aqueous solutions of Mn2+ and Cu2+ (obtained from commercial atomic absorption 424 
standard solutions) (Figure 2, Bottom Panel).  Thorough washing (5 times) of gallstones 425 
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from GF SW mice with Chelex-treated Milli-Q water resulted in a loss of the signals 426 
attributed to the transition metal ions observed in twice washed gallstones and in 427 
gallbladder bile.  The loss of the signals was gradual (i.e., decreased signal intensities 428 
with more washing); after five washes, the transition metal ions were either undetectable 429 
or significantly reduced (<10% of intensity), compared to gallstones washed twice.  In 430 
contrast to prior studies, our results show that the transition metal ion signals likely arise 431 
from the gallbladder bile rather than the gallstones (7, 13).     432 
Consistent with the presence of bilirubin radicals, a sharp signal at g = 2.00 was 433 
also observed in the twice washed gallstone and gallbladder bile samples.  In contrast to 434 
the transition metal ion signals, this radical signal persisted in the gallstones washed five 435 
times, indicating that the signal likely arises from a species in the gallstones themselves 436 
(Figure 2, Middle Panel).  The possibility of another radical species, or the presence of 437 
other radicals that are not detectable under these conditions, cannot be ruled out from 438 
these experiments. 439 
Hemograms and urinalysis were normal in GF SW mice, but serum cholesterol was 440 
elevated, and serum glucose was positively related to increasing age  441 
Of the 23 GF and 6 SPF SW mice evaluated for CBC, 9 female and 7 male GF SW mice 442 
had gallstones, while only 1 female SPF SW mouse showed gallstones.  There were no 443 
statistically significant differences in CBC analytes related to presence of gallstones, 444 
microbial status, age, sex or body weight in SW mice, and all analytes were comparable 445 
to reference values (Table 4) (14, 21).   446 
No statistically significant differences in serum chemistry analytes analyzed by 447 
IDEXX from 26 GF SW and 9 SPF SW mice were related to presence of gallstones (GF 448 
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SW mice: n = 10 females, 6 males with gallstones; SPF SW: n = 0 with gallstones), but 449 
microbial status, age, sex and body weight had significant effect(s) (Table 5).  Serum 450 
chemistries were unremarkable except for elevated serum cholesterol in GF SW, and 451 
elevated serum glucose in GF and SPF SW mice compared to the reference values (Table 452 
5) (21, 39, 40).  Differences in serum cholesterol were related to microbial status [F(1, 453 
23) = 4.96, p<0.05], with GF SW mice (245 ± 12 mg/dL) having higher values than SPF 454 
SW mice (174 ± 28 mg/dL), controlled for presence of gallstones, age, sex and body 455 
weight.  Differences in serum glucose were related to increasing age [F(1, 29) = 15.29, 456 
p<0.001], with the effect pronounced in GF SW mice (238 ± 14 mg/dL, p<0.01; SPF SW 457 
mice: 219 ± 27 mg/dL).  The remaining differences (indirect bilirubin, alanine 458 
aminotransferase, blood urea nitrogen, phosphorus) were evaluated but not clinically 459 
meaningful, as noted in Table 5. 460 
Urine samples from GF SW mice (n = 14; 8 females, 1 male with gallstones) 461 
appeared grossly normal and were negative for bilirubin and glucose.  Urobilinogen 462 
levels were ≤ 0.2 mg/dL, which was the lowest detectable limit of the urinalysis strip.  463 
Ketonuria (5.0 to 80 mg/dL) was observed in 5 female mice, 4 of which had gallstones, 464 
and protein levels varied from none to 100 mg/dL.  Urine pH was 6.0 in all samples, and 465 
the specific gravity of 5 urine samples ranged from 1.010 to 1.025.  Urine samples from 5 466 
female SPF SW retired breeders, 2 of which had gallstones, were also negative for 467 
glucose, and were otherwise within normal clinical limits.  468 
Glucose tolerance testing in GF and SPF SW mice was normal 469 
Glucose tolerance testing of 9-month-old GF (n = 11; 5 females, 4 males with gallstones) 470 
and SPF (n = 12; 3 females, 1 male with gallstones) SW mice was normal (Figure 3).  471 
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There were no significant differences in baseline blood glucose between groups, except 472 
that GF SW males (174 ± 8 mg/dL) had slightly higher levels compared to GF SW 473 
female mice (141 ± 11 mg/dL) (p<0.05) (Figure 3).  The mean AUCs of all groups were 474 
statistically the same (Figure 3).  There was no significant difference between the body 475 
weights of the GF (48.8 ± 1.0 grams) and SPF (48.5 ± 2.0 grams) SW mice evaluated for 476 
diabetes, including by sex, though mice were obese.   477 
Additionally, there were no significant differences in serum glucose (GF SW 478 
mice: 167 ± 24 mg/dL; SPF SW mice: 210 ± 22 mg/dL) or insulin (GF SW mice: 2.6 ± 479 
0.9 ng/mL; SPF SW mice: 3.5 ± 0.8 ng/mL) levels of 9-month-old SW mice, related to 480 
presence of gallstones, microbial status, age, sex or body weight.  There was also no 481 
significant difference in HbA1c levels (GF SW mice: 4.3 ± 0.2 %; SPF SW mice: 4.1 ± 482 
0.2 %) of 12-month old SW mice (GF SW mice: n = 8; 4 females, 4 males with 483 
gallstones; SPF SW mice: n = 6; 1 female with gallstones), but increasing body weight 484 
positively related to serum glucose [F(1, 9) = 8.08, p<0.05] in SPF SW mice (162 ± 28 485 
mg/dL, p<0.05; GF SW mice: 251 ± 22 mg/dL).  Note that two HbA1c levels were below 486 
the detectable limit, so the lowest registered levels were used for statistical analysis (GF 487 
SW mouse: <3.83 %; SPF SW mouse: <3.59 %). 488 
GF SW mice developed low-grade gallbladder and portal inflammation, compared 489 
to SPF SW mice  490 
Of the 26 GF SW mice evaluated histologically, 18 mice had gallstones, though presence 491 
of gallstones had no effect on gallbladder lesion scores.  Tissue samples from SPF SW 492 
mice with gallstones were not evaluated histologically, but 12 SPF SW mice without 493 
gallstones were examined.  Compared to SPF SW mice that had none to minimal 494 
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gallbladder pathology (Figure 4E-F), GF SW mice had mild to moderate (i.e. low-grade) 495 
inflammation of the gallbladder (median: 1.0; range: 0.3-2.5; p<0.001), with 496 
mononuclear infiltrates consisting predominantly of lymphocytes, plasma cells and 497 
macrophages, with variable numbers of neutrophils and mast cells (Figure 4A-D).  Mild 498 
to moderate edema (median: 1.0; range: 0.0-2.0; p<0.05) and epithelial hyperplasia 499 
(median: 1.0; range: 0.0-2.0; p<0.01) had also developed, while hyalinosis, metaplasia 500 
(GF SW males > females; p<0.05) and dysplasia were absent or minimal (Figure 4A-D).  501 
 SPF SW mice showed no or only minimal inflammation in the liver, while GF 502 
SW mice displayed significantly higher hepatitis index scores (median: 0.5; range: 0.0-503 
4.0; p<0.05) than SPF SW mice consisting of minimal to mild mononuclear portal 504 
inflammation (median: 0.5; range: 0.0-2.0; p<0.001), minimal to mild biliary hyperplasia 505 
(associated with gallstones, p<0.05), and variable hepatocellular fatty change in a few 506 
mice.  Three GF SW mice had unrelated liver pathology, including vascular lesions and 507 
lymphoma, and hence were not used for quantitative liver lesion analysis. 508 
The pancreas of most mice was normal with adequate size and distribution of 509 
islets.  However, in a few mice, there was some segmental lobular reduction in islet 510 
size/number, and small perivascular and periductal mononuclear cellular aggregates in 511 
one or two foci, with or without intra-islet infiltration.  The kidneys of a majority of GF 512 
and SPF SW mice contained variable degrees of background pathological changes 513 
consistent with lymphoma and glomerulonephritis/nephropathy.  Of those mice evaluated 514 
histologically, GF SW mice (13.0 ± 1.0 months old) were older than SPF SW mice (9.5 ± 515 
0.3 months old) (p<0.05), but body weights were the same. 516 
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Aged GF and SPF SW mice had decreased basal activity and altered agonist-517 
induced activation of the gallbladder smooth muscle 518 
Gallbladder smooth muscle activity can be assessed by evaluating Ca2+ transients under 519 
resting conditions and in response to agonist application.  Ca2+ flashes correspond to 520 
synchronous smooth muscle action potentials, which are initiated by interstitial cells of 521 
Cajal in the gallbladder, and Ca2+ waves are transient increases in Ca2+ release from 522 
intracellular stores (2, 3, 26).  Gallbladder smooth muscle activity was evaluated in 4 10-523 
month-old female GF SW mice with gallstones and 4 age-matched female SPF SW mice, 524 
1 with gallstones.  Basal activity of both aged GF and SPF SW mouse gallbladder smooth 525 
muscle was quiescent, with only occasional Ca2+ waves observed; however, carbachol 526 
induced rhythmic, synchronized Ca2+ flashes were present in 3 of 4 preparations from 527 
both groups (Figure 5).  The frequencies of the agonist-induced flashes in aged GF (0.32 528 
± 0.06 Hz) and SPF (0.42 ± 0.01 Hz) SW mice were comparable, but were slower than 529 
the Ca2+ flash frequencies observed in 7-10-week-old SPF SW mice (0.63 ± 0.02 Hz; 530 
p<0.05) 2-10 min after the application of the agonist.  In young SPF SW mice, the peak 531 
flash frequency in response to carbachol occurred within 2-10 min, and this was also 532 
observed in aged SPF SW mice.  However, in 2 of the 3 responsive aged GF SW mice, 533 
the peak in flash frequency was not reached until 15-18 min. 534 
GF SW mice demonstrated impaired gallbladder emptying in response to CCK  535 
GF (n = 19; 7 females, 8 males with gallstones) and SPF (n = 15; 1 female, 3 males with 536 
gallstones) SW mice were evaluated for responsiveness to exogenous CCK by 537 
determination of % gallbladder emptying through comparison of gallbladder volumes to 538 
mice receiving no CCK (GF SW mice: n = 18; 7 females, 9 males with gallstones; SPF 539 
24 
SW mice: n = 16; 0 females, 5 males with gallstones).  Data from control mice injected 540 
with sterile PBS or no injection were combined into one group after it was determined 541 
that gallbladder volumes were identical between control groups.   542 
Significant differences in gallbladder volume determined by ANCOVA were 543 
unrelated to presence of gallstones, age or body weight, but related to microbial status 544 
[control mice: F(1, 29) = 35.82, p<0.0001; experimental mice: F(1, 29) = 31.60, 545 
p<0.0001] and sex [control mice: F(1, 29) = 8.82, p<0.01] (Figure 6).  GF SW mice 546 
showed greater gallbladder volumes in both CCK dose groups (control mice: 170.1 ± 547 
10.5 µL; experimental mice: 142.4 ± 12.4 µL), compared to SPF SW mice (control mice: 548 
64.3 ± 11.3 µL; experimental mice: 15.0 ± 14.7 µL) (Figure 6).  When analysis was 549 
stratified by microbial status, a difference in gallbladder volume in GF SW controls due 550 
to sex was found to be non-significant, whereas a significant effect was maintained in 551 
SPF SW controls (p<0.0001), with females (87.3 ± 15.4 µL) possessing greater 552 
gallbladder volumes than males (43.8 ± 11.5 µL) (Figure 6).   553 
No significant difference was found in gallbladder volume related to CCK dose 554 
group in GF SW mice, but there was a difference in SPF SW mice (p<0.0001), where 555 
SPF SW mice receiving CCK (15.0 ± 14.7 µL) showed lower gallbladder volumes than 556 
mice in the control group (64.3 ± 11.3 µL)  (Figure 6).  Compared to SPF SW mice, GF 557 
SW mice exhibited substantially reduced gallbladder emptying in response to CCK; GF 558 
SW female mice demonstrated 29.0% emptying compared to 89.0% emptying in SPF SW 559 
female mice, and only 1.2% emptying occurred in GF SW males, with 53.4% emptying 560 
in SPF SW males (Figure 6). 561 
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SW mice showed no evidence of induced enterohepatic cycling of unconjugated 562 
bilirubin 563 
GF (n = 27; 18 females, 8 males with gallstones) and SPF (n = 22; 3 females, 1 male with 564 
gallstones) SW mice were evaluated for EHC of UCB by determination of bilirubin 565 
concentrations (µM), bilirubin secretion rates (nmol/hr) and % UCB in the hepatic bile. 566 
Significant differences were unrelated to presence of gallstones or body weight, but 567 
related to microbial status [conjugated bilirubin concentration: F(1, 43) = 11.66, p<0.01], 568 
age [UCB concentration: F(1, 43) = 6.12, p<0.05; UCB secretion rate: F(1, 43) = 4.39, 569 
p<0.05; inverse relationships], and sex [conjugated bilirubin concentration: F(1, 43) = 570 
14.38, p<0.001; % UCB: F(1, 43) = 13.28, p<0.001] (Figure 7).  GF SW mice had lower 571 
conjugated bilirubin concentrations (87.6 ± 16.3 µM) compared to SPF SW mice (193.0 572 
± 19.0 µL) (Figure 7A).   573 
When analysis was stratified by microbial status, differences in % UCB due to sex 574 
in GF SW mice, and differences in UCB concentration and secretion rate due to age in 575 
GF and SPF SW mice were found non-significant.  Significant effects were maintained 576 
on conjugated bilirubin concentrations in both GF (p<0.01) and SPF (p<0.05) SW mice, 577 
with females (GF SW mice: 111.4 ± 16.8 µM; SPF SW mice: 216.8 ± 20.7 µM) having 578 
greater conjugated bilirubin concentrations than males (GF SW mice: 33.7 ± 22.8 µM; 579 
SPF SW mice: 139.1 ± 22.4 µM).  Likewise, % UCB in SPF SW mice was greater in 580 




This study documented gallstones morphologically and compositionally consistent with 584 
“black” pigment gallstones of humans in 84% of females and 65% of males, for an 585 
overall prevalence of 75% (169/224) in GF SW mice (23, 33).  The classic etiologic 586 
associations between “black” pigment gallstones in humans and chronic hemolysis and 587 
ineffective erythropoiesis were not detected in GF SW mice, as hemograms reflected 588 
normal erythroid values and morphology.  Likewise, GF SW mice did not have increased 589 
concentration, secretion rate or % of UCB in hepatic bile, showing a lack of EHC of 590 
UCB.  Markedly enlarged gallbladders were observed in GF SW mice with impaired 591 
CCK-induced gallbladder emptying and inactive Ca2+ responses, consistent with an 592 
inherent abnormal gastrointestinal physiology in GF mice characterized by slower 593 
intestinal transit (9, 34, 35, 50, 59).  The combination of impaired responsiveness to 594 
CCK, weak basal smooth muscle activity and excess sediment may have contributed to 595 
biliary stasis, though a strictly mechanical effect on gallbladder motility due to presence 596 
of gallstones is highly unlikely, as GF SW mice with and without gallstones had enlarged 597 
fasting gallbladders and impaired gallbladder emptying in response to CCK.  Exposure to 598 
gut microbiota also appeared to protect against the formation of “black” pigment 599 
gallstones, as only 30 of 128 SPF SW mice developed gallstones (23%).  Our findings 600 
suggest genetic, age, sex and body weight predispositions, and impaired gallbladder 601 
motility, along with a microbiota-associated protective component to the pathogenesis of 602 
“black” pigment gallstone formation in SW mice.  603 
The apparent genetic predisposition and age related increases in prevalence of 604 
“black” pigment gallstones in GF SW mice are similar to the epidemiology of pigment 605 
gallstone disease in humans (5, 32).  In humans, genetic factors may be responsible for at 606 
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least 25% of symptomatic gallstone disease, although the true role of heredity is likely 607 
underestimated due to undetected asymptomatic prevalence (22, 32, 46).  SW mice are an 608 
outbred stock with a long history of experimental study since 1932; however, a known 609 
genetic predisposition to “black” pigment gallstones in either the GF or SPF status has 610 
not been noted (6).  Given that pigment gallstones have only been observed in our colony 611 
of GF SW mice, and not in 3 other strains of GF mice on distinct genetic backgrounds, 612 
the mechanism(s) underlying formation in SW mice may involve one or more 613 
spontaneous mutations affecting gastrointestinal physiology, glucoregulatory function or 614 
lipopigment metabolism.   615 
Specifically, physiologically important mutations or altered regulation may have 616 
occurred in genes of the gut-liver axis, such as fibroblast growth factor 15 (FGF15) and 617 
CCK, which regulate gallbladder filling and emptying, respectively (8, 11, 37).  A recent 618 
study established a mechanism in GF SW mice whereby increased tauro-beta-muricolic 619 
acid acts as a naturally occurring farnesoid X receptor (FXR) antagonist, with subsequent 620 
downregulation of FGF15 (42).  In a non-sterile gut, bile acids are known to induce 621 
FGF15 synthesis and suppress CCK secretion, with FGF15 opposing actions of CCK on 622 
the gallbladder (8, 42).  It has been previously shown that GF mice have a lower 623 
concentration of CCK in the intestinal tract and delayed intestinal transit (34, 35, 50).  624 
One of the roles of the commensal gut microbiota may be to increase CCK concentration, 625 
in order to maintain intestinal transit to promote colonization resistance to pathogenic 626 
bacteria (34, 35, 50).  The interaction between FGF15 and CCK in GF mice has not been 627 
studied directly, but it is likely that the above described downregulation of FGF15 and 628 
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the lower concentration of CCK in the intestinal tract in GF mice both play a role in 629 
gallbladder dysfunction (34, 35, 42).  630 
Furthermore, our study showed that female GF SW mice are 3 times more likely 631 
to develop pigment gallstones than males.  Both GF and SPF SW female mice had greater 632 
fasting gallbladder volumes compared to males, which may be due to the inhibitory effect 633 
of progesterone on the contractility of gastrointestinal smooth muscle, including the 634 
gallbladder, acting through multiple signaling pathways (24).  Gallbladder stasis can 635 
occur in pregnant women and is due to high progesterone increasing fasting residual 636 
gallbladder volume and decreased emptying capacity (24). 637 
Evaluation of spontaneous and agonist-activated Ca2+ transients (increases in 638 
intracellular [Ca2+]) in gallbladder smooth muscle has previously been validated as a 639 
useful approach for evaluating muscle activity (2, 3).  Normal gallbladder smooth muscle 640 
activity is typically associated with rhythmic, spontaneous Ca2+ flashes that correspond to 641 
action potentials occurring simultaneously in all cells of a muscle bundle, and are used as 642 
an index of basal smooth muscle tone of the gallbladder (2, 3).  Additionally, transient, 643 
spontaneous Ca2+ waves represent Ca2+ release from inositol triphosphate channels (2).  644 
Aged GF and SPF SW mice both had deficits in basal and agonist-induced gallbladder 645 
smooth muscle activity, compared to young SPF SW mice.  Defects in gallbladder 646 
muscle function may reflect oxidative stress damage observed with older age, among 647 
other factors, and promote formation of a small nucleus of precipitated calcium 648 
bilirubinate, the principal component of “black” pigment gallstones, with subsequent 649 
growth by accretion (2, 11, 20).  Furthermore, free radical attack of singlet oxygen may 650 
have contributed to polymerization and oxidation of calcium bilirubinate, wherein free 651 
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radical signal amplitude likely generated from UCB was linearly correlated with pigment 652 
content of gallstones (4, 13, 54).  653 
Irrespective of grossly observable gallstones, GF SW mice developed mild to 654 
moderate gallbladder inflammation, edema, and epithelial hyperplasia, and mild portal 655 
inflammation, compared to SPF SW mice.  Gallbladder inflammation may have resulted 656 
from the toxic or immune response-modulating properties of UCB, and/or from free 657 
radical-mediated oxidative stress (43, 54).  Cholecystitis in cholesterol gallstone disease 658 
has been associated with impaired gallbladder motility, including altered CCK-induced 659 
smooth muscle contraction, but has not been found to contribute to gallbladder stasis in 660 
“black” pigment gallstone formation (16, 31, 37, 51).  We reason that the observed mild 661 
pathology in the gallbladders of GF SW mice both contributed to and resulted from 662 
impaired gallbladder motility. 663 
The increased prevalence of “black” pigment gallstones, particularly in older and 664 
heavier female GF SW mice, is consistent with a previous report by our group.  665 
Gallstones lacking cholesterol content were found as an incidental finding in aged, obese 666 
female SPF SW mice that were part of a breeding colony used to characterize a male-667 
predominant SPF SW mouse model of non-insulin dependent diabetes mellitus (29).  668 
Type II diabetes mellitus was not substantiated in GF or SPF SW mice by normal glucose 669 
tolerance testing, mean fasting serum glucose levels below 300 mg/dL, an absence of 670 
glucosuria, and normal insulin and HbA1c levels (29, 39, 40).  Although, there was a 671 
positive relationship between serum glucose and age in GF SW mice.  Hyperglycemia 672 
inhibits bile secretion from the liver and impairs gallbladder contraction, leading to bile 673 
stasis and gallstone formation, and is augmented by diabetic autonomic neuropathy (5, 674 
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12, 37, 54).  One study found that diabetic Taiwanese were twice as likely to develop 675 
presumed pigment gallstones, compared to non-diabetic patients (5, 15).  Increased risk 676 
for both pigment and cholesterol gallstones in humans with diabetes mellitus is most 677 
likely due to metabolic syndrome, and is confounded by age, obesity and a family history 678 
of gallstones (5, 45, 46).  Epigenetic factors, specifically variations in gut microbiota, 679 
have been causally linked to the development of diabetes (1, 16, 28).  A potential genetic 680 
predisposition to diabetes and/or a tendency for development of metabolic syndrome in 681 
SW mice, combined with differences in exposure to microbes, all likely play a role in the 682 
observed variations in glucoregulatory function and lipid metabolism in SW mice.  683 
As in cholesterol gallstone disease, cholesterol may also play a role in the 684 
observed increased fasting gallbladder volumes and impaired CCK-induced gallbladder 685 
emptying in GF SW mice documented in this study.  Biliary hypersecretion of cholesterol 686 
can cause gallbladder immotility, and prolonged intestinal transit may allow for 687 
hyperabsorption of cholesterol from the gut (27, 36, 37, 58, 60, 61).  Cholesterol 688 
incorporation into the sarcolemmal membranes of gallbladder and intestinal smooth 689 
muscle cells decreases turnover of CCK-1R, the cognate receptor of CCK-8, with 690 
subsequent interrupted ligand-receptor interaction, thus impairing muscle contraction 691 
through blocked CCK signaling (10, 36, 37, 58, 61).  This relationship has been 692 
elucidated with a targeted deletion of CCK-1R in mice showing increased gallstone 693 
susceptibility, delayed small intestinal transit and increased biliary cholesterol secretion, 694 
and more recently in CCK knockout mice with enlarged fasting gallbladder volumes and 695 
impaired postprandial response of the gallbladder (57, 58, 61).  Also, increased 696 
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susceptibility to cholesterol gallstones in GF mice compared to mice with indigenous 697 
microbiota was related to larger gallbladders and gallbladder inflammation (16).  698 
One study using human subjects found that patients with “black” pigment 699 
gallstones had moderately impaired gallbladder motility characterized by delayed and 700 
incomplete postprandial emptying, but these patients had normal fasting gallbladder 701 
volumes and biliary cholesterol saturation indices (36).  Irrespective that Portincasa et al. 702 
reported human patients with “black” pigment gallstones do not have excess biliary 703 
cholesterol, this mechanism is still worthwhile to explore in GF SW mice with known 704 
delayed intestinal transit and increased serum cholesterol levels (36, 37).  The hypomotile 705 
gallbladder of GF SW mice may not only be prolonging the residence time of UCB, but 706 
also of cholesterol (36, 58).  Defective interaction of CCK with CCK-1R may also 707 
explain why GF SW mice did not respond to exogenously administered CCK as robustly 708 
as SPF SW mice.  Another possibility is that, because of the lower CCK concentration in 709 
the small intestine of GF mice, receptors may be present in lower numbers.  A 710 
combination of decreased intestinal concentration of CCK and density of CCK-1 711 
receptors, from cholesterol incorporation in the gallbladder and/or receptor 712 
downregulation, may both contribute to the major defects observed in gallbladder 713 
motility and subsequent “black” pigment gallstone formation in GF SW mice. 714 
This study documents a systematic and detailed description of a new animal 715 
model of “black” pigment gallstone formation, and suggests additional experiments to 716 
elucidate the molecular mechanism(s) that are responsible for cholelithogenesis.  Further 717 
studies could probe the possibility of biliary cholesterol supersaturation as a factor in the 718 
observed impaired gallbladder motility in GF SW mice.  This work could involve 719 
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complete hepatic and gallbladder bile chemistry profiles of GF and SPF SW mice, tests to 720 
determine cholesterol content in the gallbladder smooth muscle, and gene expression 721 
analyses, most importantly of CCK-1R.  Future experiments should also explore the 722 
altered gut-liver axis in a sterile gut, specifically the interplay of FGF15 and CCK on 723 
gallbladder function, and the gallstone protective components of the commensal 724 
microbiota. 725 
We theorize that features of GF physiology, including decreased intestinal CCK 726 
concentration and delayed intestinal transit, as well as an apparent genetic predisposition 727 
of the SW stock, contributed to the spontaneous formation of “black” pigment gallstones 728 
in GF SW mice.  It is likely that histomorphological alterations in the gallbladder, 729 
progesterone in females, increasing serum glucose with age, obesity and a predisposition 730 
to diabetes and/or metabolic syndrome, and elevated serum cholesterol all played a role 731 
in the increased fasting residual gallbladder volume, weak basal gallbladder smooth 732 
muscle activity and impaired CCK-induced gallbladder emptying.  GF SW mice should 733 
continue to be a valuable animal model to study impaired gallbladder motility as one 734 
contributing cause of “black” pigment gallstones in humans in the absence of 735 
hyperbilirubinbilia. 736 
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Figure 1.  Gallbladders of germfree (GF) Swiss Webster (SW) mice were markedly 957 
enlarged and 75% contained gallstones grossly and microscopically consistent with 958 
“black” pigment gallstones.  Panel A: Twelve-month-old female GF SW mouse with 959 
dilated gallbladder containing gallstones (arrow). B: Excised gallbladder with gallstones 960 
from a 12-month-old female GF SW mouse.  Gallstones were present in varying number, 961 
size and color, but were often dark brown to black, as pictured here.  Black bar indicates 962 
1 cm.  C: Eppendorf tube containing gallstones and gallbladder bile from a 12-month-old 963 
female GF SW mouse.  D: Gallbladder volumes (µL) and E: gallbladder bile pHs of SW 964 
mice were reported as adjusted mean ± standard error, with age and body weight fixed at 965 
their means (n = 41; mean age: 11.4 months; mean body weight: 44.9 grams).  Asterisks 966 
indicate level of significance of differences in gallbladder volume and bile pH, related to 967 
microbial status, with *** p<0.001, ** p<0.01; note that the gallbladder bile samples of 968 
GF SW mice were acidic.  Statistically significant differences in analytes related to sex in 969 
the overall model were noted (#), and if also found significant when stratified by 970 
microbial status, were marked by a difference in letters (a-b; c-d) (gallbladder volume: 971 
GF SW mice: p<0.01, SPF SW mice: p<0.001).  F: Gallstones and sediment in 972 
gallbladder bile from a 15-month-old female GF SW mouse at 100x magnification, under 973 
direct light.  G: Direct light microscopy of a gallstone from a 15-month-old female 974 
specific pathogen-free (SPF) SW mouse viewed at 200x magnification.  H:  Polarized 975 
light microscopy at 40x magnification of gallstones present on the mucosal surface of the 976 
gallbladder of an 11-month-old GF SW mouse; one gallstone appears to be broken.  I: 977 
High magnification view (100x) of a gallstone in gallbladder bile from an 11-month-old 978 
GF SW mouse viewed under polarized light.     979 
39 
 980 
Figure 2.  Electron paramagnetic resonance (EPR) spectra of gallstones and 981 
gallbladder bile.  Top Panel: Bilirubin (A) and gallstone samples from germfree (GF) 982 
(B) and specific pathogen-free (SPF) (C) Swiss Webster (SW) mice, highlighting the 983 
organic radical observed at g = 2.  A: A sample of commercial bilirubin (10 µM in 984 
Chelex-treated Milli-Q water) contained a derivative EPR signal centered at g = 2.00.  985 
Additional features were observed at g = 2.04 and g = 1.98.  B: EPR spectrum of 986 
gallstones obtained from GF SW mice.  Spectrum B contained a derivative feature 987 
centered at g = 2.0 attributed to bilirubin radicals.  An additional feature was observed at 988 
g = 1.98.  Multiple additional features that display weak signal intensities were observed 989 
at lower field and may indicate the presence of additional EPR-detectable species in the 990 
sample.  C: EPR spectrum of gallstones from one SPF SW mouse.  The spectrum is 991 
scaled by 5x to facilitate comparison with spectra A and B.  A derivative feature centered 992 
at g = 2.00 was also observed, and multiple weak features were present in the baseline.  993 
Instrument conditions: temperature, 5 K; microwaves, 20.1 µW at 9.4 GHz; modulation 994 
amplitude, 1 mT.  Middle Panel: EPR spectra of gallstones and gallbladder bile from GF 995 
SW mice.  D: Spectrum of twice washed gallstones.  E: Spectrum of undiluted 996 
gallbladder bile.  F: Spectrum of gallstones washed five times.  Instrument conditions: 997 
temperature, 20 K; microwaves, 0.2 mW at 9.4 GHz.  Bottom Panel: Expanded view of 998 
the EPR signals in the g = 2 region from spectrum E.  The Mn2+ and Cu2+ signals were 999 
obtained from standards of each metal ion (prepared in Milli-Q water).  The Mn2+ + Cu2+ 1000 
spectrum was generated through a linear combination of the Mn2+ and Cu2+ standard 1001 
spectra.  Because it was necessary to record the spectra under non-ideal spectroscopic 1002 
40 
conditions (higher power) to observe and maximize signals for the transition metal ions, 1003 
the radical signal at g ~ 2 is saturated, resulting in loss of the characteristic derivative 1004 
signal that is apparent under ideal spectroscopic conditions in the Top and Middle Panels.  1005 
Instrument conditions: temperature, 20 K; microwaves, 0.2 mW at 9.4 GHz. 1006 
 1007 
Figure 3.  Normal glucose tolerance testing results from 9-month-old germfree (GF) 1008 
SW (Swiss Webster) and specific pathogen-free (SPF) SW mice.  The mean area 1009 
under the curves (AUC) of all groups compared were statistically the same, including not 1010 
pictured SPF SW mice with or without gallstones, and SPF SW females or males.  Panel 1011 
A: GF SW mice (n = 11; 79.8 ± 6.9) compared to SPF SW mice (n = 12; 93.8 ± 6.9).  B: 1012 
GF SW mice with gallstones (n = 9; 80.5 ± 7.9) compared to GF SW mice without 1013 
gallstones (n = 2; 77.0 ± 15.0).  C: GF SW females (n = 6; 84.2 ± 9.8) compared to GF 1014 
SW males (n = 5; 74.6 ± 9.9).  Mean baseline blood glucose values were significantly 1015 
higher in GF SW male mice, compared to GF SW female mice, * p<0.05.   1016 
 1017 
Figure 4.  H&E images of the range of gallbladder lesions in germfree (GF) Swiss 1018 
Webster (SW) (A - D) compared to specific pathogen-free (SPF) SW (E & F) mice.  1019 
Panel A: Gallbladder of an 8-month-old male GF SW mouse with gallstones, showing 1020 
mild sub-epithelial inflammation, edema and epithelial hyalinosis (intensely eosinophilic 1021 
granular hyaline-like cytoplasmic alteration).  B: Gallbladder of an 8-month-old female 1022 
GF SW mouse without gallstones showing moderate mixed (lymphocytic and 1023 
granulocytic) inflammation of the epithelium and stroma with minimal papillary 1024 
epithelial projections.  C: Low magnification image of a gallbladder of an 8-month-old 1025 
41 
male GF SW mouse without gallstones, showing prominent papillomatous epithelial 1026 
hyperplasia, scattered inflammatory cells and edema in the sub-epithelial space/stroma.  1027 
D: Higher magnification of C, showing hyperplastic long columnar epithelium with 1028 
mostly basal oval nuclei, abundant eosinophilic to vacuolated (mucous) cytoplasm, and 1029 
an intra-glandular protein cast (arrow).  E and F: Low and high magnification images of 1030 
a gallbladder of a 10-month-old male SPF SW mouse with sparse inflammatory cells and 1031 
mild papillary epithelial hyperplasia.  Bars: A, B and F = 80 µM; C and E = 160 µM; D 1032 
= 40 µM. 1033 
 1034 
Figure 5.  Gallbladder smooth muscle activity is disrupted in aged germfree (GF) 1035 
and specific pathogen-free (SPF) Swiss Webster (SW) mice.  Ca2+ transient recordings 1036 
from pairs of gallbladder smooth muscle cells (gray and black) showing an age-related 1037 
disruption in spontaneous activity.  Gallbladder smooth muscle cells in young SPF SW 1038 
mice exhibit synchronized rhythmic Ca2+ flashes (upper left panel).  Ca2+ flash activity is 1039 
absent in 10-month-old GF and SPF SW mice (center and bottom left panels), where only 1040 
Ca2+ waves were detected.  Carbachol (3 uM) induced Ca2+ flashes in all 3 groups of 1041 
mice once peak frequency was reached (right panels; time point indicated above each 1042 
trace).    1043 
 1044 
Figure 6.  Germfree (GF) Swiss Webster (SW) mice showed impaired 1045 
cholecystokinin (CCK)-induced gallbladder emptying, compared to specific 1046 
pathogen-free (SPF) SW mice.  Gallbladder volumes (µL) of SW mice were reported as 1047 
adjusted mean ± standard error, with age and body weight fixed at their means (control 1048 
42 
mice: n = 34; mean age: 8.0 months; mean body weight: 55.0 grams; experimental mice: 1049 
n = 34; mean age: 8.0 months; mean body weight: 55.7 grams).  Asterisks indicate level 1050 
of significance of differences in gallbladder volumes of control and experimental mice, 1051 
related to microbial status, with **** p<0.0001.  Statistically significant differences in 1052 
gallbladder volume related to sex in the overall model were noted (#), and if also found 1053 
significant when stratified by microbial status, were marked by a difference in letters (a-1054 
b) (SPF SW mice: p<0.0001).  A difference in numbers (1-2) denotes a statistically 1055 
significant difference in gallbladder volume between SPF SW control and experimental 1056 
mice (p<0.0001). 1057 
 1058 
Figure 7.  Germfree (GF) Swiss Webster (SW) and specific pathogen-free (SPF) SW 1059 
mice were comparable in concentration, secretion rate and % of unconjugated 1060 
bilirubin (UCB) in hepatic bile.  Panel A: Bilirubin concentrations (µM), B: secretion 1061 
rates (nmol/hr) and C: % UCB of hepatic bile of SW mice were reported as adjusted 1062 
mean ± standard error, with age and body weight fixed at their means (n = 49; mean age: 1063 
11.2 months; mean body weight: 54.8 grams).  Asterisks indicate level of significance of 1064 
difference in conjugated bilirubin concentration, related to microbial status, with ** 1065 
p<0.01.  Statistically significant differences in analytes related to sex in the overall model 1066 
were noted (#), and if also found significant when stratified by microbial status, were 1067 
marked by a difference in letters (a-b; c-d) (conjugated bilirubin concentration: GF SW 1068 
mice: p<0.01, SPF SW mice: p<0.05; % UCB: SPF SW mice: p<0.05). 1069 
Mean	  ±	  SE Range Mean	  ±	  SE Range
GF	  SW	  Mice
	  	  	  	  	  All 224 75% 10.7	  ±	  0.2 5	  -­‐	  22 48.6	  ±	  0.6 28.6	  -­‐	  75.6
	  	  	  	  	  Gallstones 169 11.1	  ±	  0.2 5	  -­‐	  22 49.8	  ±	  0.7 31.3	  -­‐	  75.6
	  	  	  	  	  No	  Gallstones 55 9.7	  ±	  0.4 5	  -­‐	  17 45.1	  ±	  1.1 28.6	  -­‐	  63.8
	  	  	  	  	  Females 125 84% 11.0	  ±	  0.3 5	  -­‐	  22 48.0	  ±	  0.8 28.6	  -­‐	  75.6
	  	  	  	  	  Males 99 65% 10.4	  ±	  0.3 5	  -­‐	  17 49.3	  ±	  0.9 29.9	  -­‐	  66.7
SPF	  SW	  Mice
	  	  	  	  	  All 128 23% 10.1	  ±	  0.2 8	  -­‐	  15 49.6	  ±	  0.8 28.6	  -­‐	  86.8
	  	  	  	  	  Gallstones 30 10.2	  ±	  0.4 8	  -­‐	  15 50.9	  ±	  1.3 40.0	  -­‐	  68.6
	  	  	  	  	  No	  Gallstones 98 10.1	  ±	  0.2 8	  -­‐	  15 49.1	  ±	  0.9 28.6	  -­‐	  86.8
	  	  	  	  	  Females 75 20% 10.5	  ±	  0.3 8	  -­‐	  15 50.3	  ±	  1.1 28.6	  -­‐	  86.8
	  	  	  	  	  Males 53 28% 9.6	  ±	  0.3 8	  -­‐	  14 48.6	  ±	  1.0 33.3	  -­‐	  63.9
Table 1. Demographic profile of germfree (GF) and specific pathogen-­‐free (SPF) Swiss Webster
(SW)	  mice
n Gallstone	  PrevalenceMicrobial	  Status
a	  Eight	  body	  weight	  values	  not	  provided.
Age	  (months) a	  Body	  Weight	  (grams)
OR 95%	  CI p-­‐value
a	  Multivariate	  Full	  Model	  (n	  =	  344) <	  0.0001
	  	  	  	  	  Microbial	  Status
	  	  	  	  	  	  	  	  	  	  GF 11.44	  (10.04) 6.57	  -­‐	  19.93	  (6.03	  -­‐	  16.71) <	  0.001	  (<	  0.001)
	  	  	  	  	  	  	  	  	  	  SPF Reference	  Group
	  	  	  	  	  Age	  (months) 1.14	  (1.16) 1.04	  -­‐	  1.26	  (1.07	  -­‐	  1.27) <	  0.01	  (<	  0.01)
	  	  	  	  	  Sex
	  	  	  	  	  	  	  	  	  	  Female 1.55	  (1.39) 0.92	  -­‐	  2.60	  (0.91	  -­‐	  2.12) 0.10	  (0.13)
	  	  	  	  	  	  	  	  	  	  Male Reference	  Group
	  	  	  	  	  b	  Body	  Weight	  (grams) 1.05	  (1.03) 1.02	  -­‐	  1.09	  (1.01	  -­‐	  1.06) <	  0.01	  (<	  0.05)
c	  Multivariate	  Reduced	  Model	  (n	  =	  344) <	  0.0001
	  	  	  	  	  Microbial	  Status 10.98 6.36	  -­‐	  18.98 <	  0.001
	  	  	  	  	  Age	  (months) 1.15 1.05	  -­‐	  1.27 <	  0.01
	  	  	  	  	  b	  Body	  Weight	  (grams) 1.05 1.02	  -­‐	  1.08 <	  0.01
Table 2. Logistic regression models of the relationship between microbial status [germfree (GF),
specific	  pathogen-­‐free	  (SPF)]	  of	  Swiss	  Webster	  (SW)	  mice	  and	  presence	  of	  gallstones	  
a In multivariate full model, odds ratios (ORs), 95% confidence intervals (CIs) and p-­‐values are
reported	  as	  adjusted	  (crude).
b	  Eight	  body	  weight	  values	  not	  provided.
c	  Favored	  model;	  excludes	  sex	  found	  non-­‐significant	  by	  likelihood-­‐ratio	  chi-­‐squared	  test.
OR 95%	  CI p-­‐value
a	  Multivariate	  Full	  Model	  (n	  =	  220) <	  0.0001
	  	  	  	  	  Age	  (months) 1.23	  (1.22) 1.08	  -­‐	  1.40	  (1.08	  -­‐	  1.39) <	  0.01	  (<	  0.01)
	  	  	  	  	  Sex
	  	  	  	  	  	  	  	  	  	  Female 3.16	  (2.87) 1.58	  -­‐	  6.29	  (1.53	  -­‐	  5.40) <	  0.01	  (<	  0.01)
	  	  	  	  	  	  	  	  	  	  Male Reference	  Group
	  	  	  	  	  b	  Body	  Weight	  (grams) 1.08	  (1.07) 1.04	  -­‐	  1.13	  (1.03	  -­‐	  1.12) <	  0.001	  (<	  0.01)
Table 3. Logistic regression model of the relationship between independent variables and
presence	  of	  gallstones	  in	  germfree	  (GF)	  Swiss	  Webster	  (SW)	  mice	  
a In multivariate full model, odds ratios (ORs), 95% confidence intervals (CIs) and p-­‐values are
reported as adjusted (crude). Multivariate full model is favored model; no covariates found non-­‐
significant	  by	  likelihood-­‐ratio	  chi-­‐squared	  test.
b	  Four	  body	  weight	  values	  not	  provided.
Female	  (n=11) Male	  (n=12) Female	  (n=3) Male	  (n=3)
White	  Blood	  Cell	  Count	  (103/ul) 4.9	  ±	  0.8 4.3	  ±	  0.7 4.0	  ±	  1.4 4.3	  ±	  1.4 5.1	  -­‐	  11.6
	  	  	  	  	  Neutrophils 1.2	  ±	  0.3 1.7	  ±	  0.2 1.2	  ±	  0.5 1.7	  ±	  0.5 0.3	  -­‐	  4.3
	  	  	  	  	  Bands 0.1	  ±	  0.0 0.0	  ±	  0.0 0.2	  ±	  0.1 0.1	  ±	  0.1 none	  to	  few
	  	  	  	  	  Lymphocytes 2.6	  ±	  0.5 2.5	  ±	  0.5 2.6	  ±	  0.9 2.5	  ±	  1.0 3.2	  -­‐	  8.7
	  	  	  	  	  Monocytes 0.1	  ±	  0.0 0.0	  ±	  0.0 0.0	  ±	  0.0 0.0	  ±	  0.0 0.0	  -­‐	  0.3
	  	  	  	  	  Eosinophils 0.0	  ±	  0.0 0.0	  ±	  0.0 0.0	  ±	  0.0 0.0	  ±	  0.0 0.1	  -­‐	  0.4
	  	  	  	  	  Basophils 0.0	  ±	  0.0 0.0	  ±	  0.0 0.0	  ±	  0.0 0.0	  ±	  0.0 0.0	  -­‐	  0.2
Red	  Blood	  Cell	  Count	  	  (106/uL) 10.3	  ±	  0.3 10.7	  ±	  0.3 9.7	  ±	  0.5 10.2	  ±	  0.6 7	  -­‐	  11
Hematocrit	  (%) 48.8	  ±	  1.5 49.7	  ±	  1.4 51.9	  ±	  2.6 52.7	  ±	  2.7 35	  -­‐	  52
Hemoglobin	  (g/dL) 13.6	  ±	  0.3 14.2	  ±	  0.3 13.9	  ±	  0.6 14.5	  ±	  0.6 10	  -­‐	  17
Platelet	  Count	  (103/uL) 1239	  ±	  147 1426	  ±	  131 1417	  ±	  246 1604	  ±	  255 900	  -­‐	  1600
Mean	  Corpuscular	  Volume	  (fL) 47.7	  ±	  1.0 46.4	  ±	  0.9 53.3	  ±	  1.8 52.0	  ±	  1.9 45	  -­‐	  55
Mean	  Corpuscular	  Hemoglobin	  (pg/cell) 13.3	  ±	  0.3 13.2	  ±	  0.2 14.3	  ±	  0.4 14.2	  ±	  0.5 15	  -­‐	  18
MCH	  Concentration	  (g/dL) 27.9	  ±	  0.6 28.5	  ±	  0.6 26.8	  ±	  1.1 27.4	  ±	  1.1 30	  -­‐	  38
Reference	  
Values
There were no statistically significant differences in analytes determined by ANCOVA related to presence of gallstones,
microbial status, age, sex or body weight. GF SW and SPF SW data represent adjusted mean ± standard error, where age
and body weight are fixed at their means (n = 29; mean age: 11.1 months; mean body weight: 44.7 grams). Of those
analyzed, 16 GF SW mice and one SPF SW mouse had gallstones. Reference data for SW mice are not published, and
reference	  intervals	  provided	  represent	  normative	  data	  for	  the	  mouse,	  and	  are	  not	  specific	  for	  strain,	  sex,	  or	  age	  (14,	  21).
Table	  4.	  	  Complete	  blood	  count	  analytes	  from	  germfree	  (GF)	  and	  specific	  pathogen-­‐free	  (SPF)	  Swiss	  Webster	  (SW)	  mice
GF	  SW	  Mice SPF	  SW	  Mice
Complete	  Blood	  Count
Female	  (n=11) Male	  (n=15) Female	  (n=4) Male	  (n=5)
Lipid	  &	  Carbohydrate	  Metabolism
	  	  	  	  	  2*	  Cholesterol	  (mg/dL) 221.5	  ±	  18.2 264.7	  ±	  14.9 150.3	  ±	  28.8 193.5	  ±	  32.1 114	  ±	  56
	  	  	  	  	  3a***	  Glucose	  (mg/dL) 226.0	  ±	  22.3 246.4	  ±	  16.4 207.7	  ±	  27.1 228.1	  ±	  32.0 112	  ±	  38
Hepatic	  Function
	  	  	  	  	  Total	  Bilirubin	  (mg/dL) 0.0	  ±	  0.0 0.1	  ±	  0.0 0.0	  ±	  0.0 0.1	  ±	  0.0 0.4	  ±	  0.2
	  	  	  	  	  Direct	  Bilirubin	  (mg/dL) 0.0	  ±	  0.0 0.0	  ±	  0.0 0.0	  ±	  0.0 0.0	  ±	  0.0 N/A
	  	  	  	  	  3a*;	  5a**	  Indirect	  Bilirubin	  (mg/dL) 0.0	  ±	  0.0 0.0	  ±	  0.0 0.0	  ±	  0.0 0.0	  ±	  0.0 N/A
	  	  	  	  	  Albumin	  (g/dL) 3.1	  ±	  0.1 3.1	  ±	  0.1 2.8	  ±	  0.2 2.8	  ±	  0.2 N/A
	  	  	  	  	  Globulin	  (g/dL) 3.2	  ±	  0.2 3.3	  ±	  0.1 3.1	  ±	  0.3 3.3	  ±	  0.3 N/A
	  	  	  	  	  Total	  Protein	  (g/dL) 6.3	  ±	  0.2 6.5	  ±	  0.2 5.8	  ±	  0.3 6.0	  ±	  0.4 4.4	  ±	  1.1
	  	  	  	  	  2**	  Alanine	  Aminotransferase	  (IU/L) 45.7	  ±	  9.0 35.4	  ±	  7.1 91.8	  ±	  14.0 81.5	  ±	  15.7 99	  ±	  86
	  	  	  	  	  Alkaline	  Phosphatase	  (IU/L) 85.3	  ±	  7.5 71.4	  ±	  5.9 59.2	  ±	  11.7 45.3	  ±	  13.1 39	  ±	  26
	  	  	  	  	  Aspartate	  Aminotransferase	  (IU/L) 143.8	  ±	  33.2 75.9	  ±	  27.0 133.1	  ±	  52.4 65.2	  ±	  58.5 196	  ±	  133
Renal	  Function
	  	  	  	  	  2*;	  4a*	  Blood	  Urea	  Nitrogen	  (mg/dL) 17.4	  ±	  1.1 21.1	  ±	  0.9 21.5	  ±	  1.7 25.2	  ±	  1.9 38	  ±	  20
	  	  	  	  	  Creatinine	  (mg/dL) 0.2	  ±	  0.0 0.2	  ±	  0.0 0.2	  ±	  0.0 0.2	  ±	  0.0 1.1	  ±	  0.5
Electrolytes,	  Acid-­‐Base	  Balance
	  	  	  	  	  Calcium	  (mg/dL) 10.1	  ±	  0.2 10.1	  ±	  0.2 10.4	  ±	  0.3 10.4	  ±	  0.3 8.9	  ±	  2.1
	  	  	  	  	  Chloride	  (mEq/L) 108.9	  ±	  1.3 111.3	  ±	  1.0 104.9	  ±	  1.8 107.4	  ±	  2.0 125	  ±	  7.2
	  	  	  	  	  4b*	  Phosphorus	  (mg/dL) 8.6	  ±	  0.5 10.1	  ±	  0.4 8.5	  ±	  0.6 10.0	  ±	  0.7 8.3	  ±	  1.5
	  	  	  	  	  Potassium	  (mEq/L) 9.6	  ±	  0.7 10.2	  ±	  0.5 8.5	  ±	  1.0 9.1	  ±	  1.1 8.0	  ±	  0.9
	  	  	  	  	  Sodium	  (mEq/L) 154.1	  ±	  2.2 157.2	  ±	  1.6 152.4	  ±	  3.0 155.6	  ±	  3.3 166	  ±	  8.6
Table	  5.	  	  Serum	  chemistry	  analytes	  from	  germfree	  (GF)	  and	  specific	  pathogen-­‐free	  (SPF)	  Swiss	  Webster	  (SW)	  mice
Statistically significant differences in analytes determined by ANCOVA are noted and relate to 1 presence of gallstones, 2	  
microbial status, 3 age (direct relationship), 4 sex or 5 body weight (inverse relationship), with a GF and/or b SPF found
responsible for significant effect(s) by ANCOVA stratified by microbial status; * p<0.05, ** p<0.01, *** p<0.001. GF SW and
SPF SW data represent adjusted mean ± standard error, where age and body weight are fixed at their means (n = 35;
mean age: 12.0 months; mean body weight: 43.6 grams). Sixteen GF SW mice had gallstones, while no SPF SW mice
analyzed had gallstones. Reference data for SW mice are not published, and reference values provided represent mean ±
standard	  deviation	  obtained	  from	  adult	  male	  CD-­‐1	  mice	  (21,	  39,	  40);	  N/A	  indicates	  no	  data	  available.
GF	  SW	  Mice SPF	  SW	  Mice




















"Black" pigment gallstones form in sterile gallbladder bile in the presence of excess bilirubin 
conjugates from ineffective erythropoiesis, hemolysis or induced enterohepatic cycling 
(EHC) of unconjugated bilirubin. Impaired gallbladder motility is a less well-studied risk 
factor. We evaluated the spontaneous occurrence of gallstones in adult germfree (GF) and 
specific pathogen-free (SPF) Swiss Webster (SW) mice. GF SW mice were more likely to 
have gallstones than SPF SW mice, with 75% and 23% prevalence, respectively, and were 
observed predominately in heavier, older females. Gallbladders of GF SW mice were 
markedly enlarged, contained sterile "black" gallstones comprised of calcium bilirubinate 
and <1% cholesterol, and had low-grade inflammation, edema and hyperplasia. 
Hemograms were normal, but serum cholesterol was elevated in GF SW mice, and serum 
glucose levels were positively related to increasing age. Aged GF and SPF SW mice had 
deficits in gallbladder smooth muscle activity. In response to cholecystokinin (CCK), 
gallbladders of fasted GF SW mice showed impaired emptying (females: 29%; males: 1% 
emptying), whereas SPF SW females and males emptied 89% and 53% of volume, 
respectively. Bilirubin secretion rates of GF SW mice were not greater than SPF SW mice, 
repudiating an induced EHC. Gallstones likely developed in GF SW mice due to gallbladder 
hypomotility, enabled by features of GF physiology, including decreased intestinal CCK 
concentration and delayed intestinal transit, as well as an apparent genetic predisposition of 
the SW stock. GF SW mice may provide a valuable model to study gallbladder stasis as a 
cause of "black" pigment gallstones.	  
